| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |